Rubrik (NYSE: RBRK) expands AI cybersecurity alliance as Code Guardian enters enterprise delivery push
Read More Pharma Industry News Ascendis Pharma bags YORVIPATH FDA approval for adult hypoparathyroidism In a landmark decision, the U.S. Food and Drug Administration (FDA) has granted approval to Ascendis Pharma A/S’s… byPallavi MadhirajuAugust 12, 2024